Inhibition of Fungal Biofilms - Antibiofilm Agents: From Diagnosis to Treatment and Prevention - page 280

Reddy BT, Torres HA, Kontoyiannis DP (2002) Breast implant infection caused by Trichosporon
beigelii. Scand J Infect Dis 34(2):143-144
Ricicova M, Kucharikova S, Tournu H, Hendrix J, Bujdakova H, Van Eldere J, Lagrou K, Van
Dijck P (2010) Candida albicans biofilm formation in a new in vivo rat model. Microbiology
156(Pt 3):909-919
Robbins N, Uppuluri P, Nett J, Rajendran R, Ramage G, Lopez-Ribot JL, Andes D, Cowen LE
(2011) Hsp90 governs dispersion and drug resistance of fungal biofilms. PLoS Pathog 7(9):
e1002257
Sanglard D, Coste A, Ferrari S (2009) Antifungal drug resistance mechanisms in fungal pathogens
from the perspective of transcriptional gene regulation. FEMS Yeast Res 9(7):1029-1050
Sardi JC, Scorzoni L, Bernardi T, Fusco-Almeida AM, Mendes Giannini MJ (2013) Candida
species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products
and new therapeutic options. J Med Microbiol 62(Pt 1):10-24
Schinabeck MK, Long LA, Hossain MA, Chandra J, Mukherjee PK, Mohamed S, Ghannoum MA
(2004) Rabbit model of Candida albicans biofilm infection: liposomal amphotericin B anti-
fungal lock therapy. Antimicrob Agents Chemother 48(5):1727-1732
Sherertz RJ, Boger MS, Collins CA, Mason L, Raad II (2006) Comparative in vitro efficacies of
various catheter lock solutions. Antimicrob Agents Chemother 50(5):1865-1868
Shuford JA, Rouse MS, Piper KE, Steckelberg JM, Patel R (2006) Evaluation of caspofungin and
amphotericin B deoxycholate against Candida albicans biofilms in an experimental intravas-
cular catheter infection model. J Infect Dis 194(5):710-713
Siles SA, Srinivasan A, Pierce CG, Lopez-Ribot JL, Ramasubramanian AK (2013) High-
throughput screening of a collection of known pharmacologically active small compounds
for the identification of Candida albicans biofilm inhibitors. Antimicrob Agents Chemother
57:3681-3687
Simitsopoulou M, Peshkova P, Tasina E, Katragkou A, Kyrpitzi D, Velegraki A, Walsh TJ,
Roilides E (2013) Species-specific and drug-specific differences in susceptibility of Candida
biofilms to echinocandins: characterization of less common bloodstream isolates. Antimicrob
Agents Chemother 57(6):2562-2570
Sousa C, Henriques M, Oliveira R (2011) Mini-review: antimicrobial central venous catheters-
recent advances and strategies. Biofouling 27(6):609-620
Srinivasan A, Uppuluri P, Lopez-Ribot J, Ramasubramanian AK (2011) Development of a high-
throughput Candida albicans biofilm chip. PLoS One 6(4):e19036
Srinivasan A, Leung KP, Lopez-Ribot JL, Ramasubramanian AK (2013) High-throughput nano-
biofilm microarray for antifungal drug discovery. mBio 4:e00331-13
Tobinick EL (2009) The value of drug repositioning in the current pharmaceutical market.
Drug News Perspect 22(2):119-125
Tumbarello M, Fiori B, Trecarichi EM, Posteraro P, Losito AR, De Luca A, Sanguinetti M,
Fadda G, Cauda R, Posteraro B (2012) Risk factors and outcomes of candidemia caused by
biofilm-forming isolates in a tertiary care hospital. PLoS ONE 7(3):e33705
Uppuluri P, Nett J, Heitman J, Andes D (2008) Synergistic effect of calcineurin inhibitors and
fluconazole against Candida albicans biofilms. Antimicrob Agents Chemother 52(3):
1127-1132
Uppuluri P, Chaturvedi AK, Srinivasan A, Banerjee M, Ramasubramaniam AK, K ¨ hler JR,
Kadosh D, Lopez Ribot JL (2010a) Dispersion as an important step in the Candida albicans
biofilm developmental cycle. PLoS Pathog 6:e1000828
Uppuluri P, Pierce CG, Thomas DP, Bubeck SS, Saville SP, Lopez-Ribot JL (2010b) The
transcriptional regulator Nrg1p controls Candida albicans biofilm formation and dispersion.
Eukaryot Cell 9(10):1531-1537
Valentin A, Canton E, Peman J, Martinez JP (2012) Voriconazole inhibits biofilm formation in
different species of the genus Candida. J Antimicrob Chemother 67(10):2418-2423